Engineers Gate Manager’s Cogent Biosciences COGT Stock Holding History

Engineers Gate Manager’s Portfolio COGT Stock Details COGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.62M	Buy	41,990 +15,623	+59%	+$577K	0.02%	815
2025 Q4	$937K	Sell	26,367 -70,119	-73%	-$1.97M	0.01%	1068
2025 Q3	$1.39M	Buy	96,486 +6,214	+7%	+$73.6K	0.02%	982
2025 Q2	$648K	Buy	90,272 +64,356	+248%	+$357K	0.01%	1352
2025 Q1	$155K	Sell	25,916 -21,018	-45%	-$165K	﹤0.01%	1942
2024 Q4	$366K	Buy	+46,934	New	+$468K	0.01%	1624
2024 Q1	–	Sell	-11,460	Closed	-$67.4K	–	1961
2023 Q4	$67.4K	Buy	+11,460	New	+$87.8K	﹤0.01%	1817
2023 Q3	–	Sell	-27,019	Closed	-$320K	–	1833
2023 Q2	$320K	Buy	27,019 +3,501	+15%	+$40.2K	0.01%	1282
2023 Q1	$254K	Sell	23,518 -785	-3%	-$10K	0.01%	1331
2022 Q4	$281K	Buy	+24,303	New	+$301K	0.02%	1214
2021 Q2	–	Sell	-18,524	Closed	-$163K	–	1666
2021 Q1	$163K	Buy	+18,524	New	+$178K	0.01%	1639

Other funds holding COGT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Engineers Gate Manager's COGT Position: Q1 2026 in Review

Engineers Gate Manager increased its Cogent Biosciences (COGT) stake by 59% in Q1 2026, buying an estimated $577K and bringing the position to 41,990 shares worth $1.62M. The position accounts for 0.02% of the portfolio, ranked #815.

Engineers Gate Manager first reported a position in COGT in Q1 2021 and has held it in 11 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

Engineers Gate Manager held 41,990 shares of Cogent Biosciences worth $1.62M as of Q1 2026.
Engineers Gate Manager bought 15,623 Cogent Biosciences shares in Q1 2026, an estimated $577K.
Cogent Biosciences made up 0.02% of Engineers Gate Manager's portfolio in Q1 2026, its #815 holding.
Engineers Gate Manager first reported a position in Cogent Biosciences in Q1 2021 and has held it in 11 quarters since.
305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.